HOAG

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Glioblastoma1 trial
• Liver and biliary tract cancer1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 22 trials

Status

• Recruiting5 trials

Lead sponsor

• Arbor Research Collaborative for Health1 trial
• Diakonos Oncology Corporation1 trial
• HistoSonics, Inc.1 trial
• ImmunityBio, Inc.1 trial
• Insulet Corporation1 trial

Running trials

• Recruiting

  Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  NCT07521475· Insulet Corporation· Source

  Contact: Brittany Dennis

• Recruiting

  DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

  NCT06805305· Phase 2· Diakonos Oncology Corporation· Source

  Contact: Julie Nguyen

• Recruiting

  A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

  NCT06710288· Phase 2· ImmunityBio, Inc.· Source

  Contact: Tiffany Beck, M.D., MPH, FACOG

• Recruiting

  Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  NCT06486454· HistoSonics, Inc.· Source

  Contact: Vicki Tan

• Recruiting

  Pancreatic Cancer Early Detection Consortium

  NCT04970056· Arbor Research Collaborative for Health· Source

  Contact: Leila Andres

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glioblastoma1 recruiting
• Liver and biliary tract cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Type 2 diabetes1 recruiting